Literature DB >> 31727484

[Post-menopausal hypertension: Detecting, treating, accompany, prevent].

Claire Mounier-Vehier1, Anne-Laure Madika2.   

Abstract

Menopause is associated with a significant increase in arterial and metabolic risk. Systolic hypertension is common in post-menopausal women. Measurement of blood pressure should be repeated systematically at each visit. Ambulatory blood pressure measurements should be encouraged, especially to detect nocturnal hypertension and to prevent more efficiently women at risk. Self-testing of hypertension by home blood pressure should be encouraged at menopause. Antihypertensive treatment should be initiated after ambulatory blood pressure monitoring in association with reinforced lifestyle. Furthermore, global level of cardiovascular risk should take into account before starting antihypertensive treatment. There are no women specificities in the choice of the initial treatment except thiazide diuretics which should be preferred in osteoporotic women. In hypertensive women and with disabling climacteric symptoms under 60 and within 10 years after the onset of menopause, post-menopausal hormone therapy can be offered in absence of arterial or venous contraindications. A preliminary discussion between gynecologist, cardiologist and general practionner is necessary before deciding to treat a post-menopausal women for her climacteric symptoms. A clear information on the benefit-risk balance of post-menopausal hormone therapy should be given to the women. The information should be recorded in the medical file. Cooperation between cardiologists, gynecologists and general practionners should be promoted in France, to optimize the care pathways in these women at risk and to improve medical practices.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Year:  2019        PMID: 31727484     DOI: 10.1016/j.lpm.2019.09.050

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloroquine with an 11-year follow-up.

Authors:  P Sabatier; M Wack; J Pouchot; N Danchin; A S Jannot
Journal:  BMC Med Res Methodol       Date:  2022-06-08       Impact factor: 4.612

2.  The imbalance in the aortic ceramide/sphingosine-1-phosphate rheostat in ovariectomized rats and the preventive effect of estrogen.

Authors:  Yao Li; Wei Zhang; Junlei Li; Yanrong Sun; Qiyue Yang; Sinan Wang; Xiaofeng Luo; Wenjuan Wang; Ke Wang; Wenpei Bai; Haicheng Zhang; Lihua Qin
Journal:  Lipids Health Dis       Date:  2020-05-19       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.